Clinical Trials Browser

Phase 1/2 × INDUSTRY × XRP6258 × Clear all

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Phase 1/2 Completed

39 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm

NCT01001221 2013-09-11

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Phase 1/2 Terminated

19 enrolled 55 charts

Neoplasms